Position in ANAB
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,071,225
-$616,064 QoQ
Shares Held
15,870
-84.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 211 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 84%
Shared 16%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. ANAB ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,875,301 | $500,180,281 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,012,317 | $376,866,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,049 | $210,141,127 | |
| 4 | TECH |
BIO-TECHNE Corp
|
2,746,462 | $194,037,538 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
2,607,348 | $143,404,140 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
375,762 | $118,774,610 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
350,560 | $105,529,075 | |
| 8 | BNTX |
BioNTech SE
|
677,708 | $63,060,728 |
All Filings in ANAB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,071,225 | 15,870 | Shares | Sole | 2026-08-03 | |
| 2022-03-31 | $1,687,289 | 68,201 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,821,843 | 81,204 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,608,808 | 96,195 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,527,064 | 97,457 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $739,877 | 34,333 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $825,598 | 38,400 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $572,062 | 38,784 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||